| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.17 | 0.006 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.41 | 0.008 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |